These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9486675)

  • 1. The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature.
    Knowles S; Gupta AK; Shear NH
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):201-6. PubMed ID: 9486675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers.
    Gonzalo Garijo MA; Pérez Calderón R; de Argila Fernández-Durán D; Rangel Mayoral JF
    Allergol Immunopathol (Madr); 2005; 33(4):238-40. PubMed ID: 16045866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse reactions associated with calcium channel blockers.
    Stern R; Khalsa JH
    Arch Intern Med; 1989 Apr; 149(4):829-32. PubMed ID: 2523214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drugs associated with acute generalized exanthematic pustulosis].
    Saissi EH; Beau-Salinas F; Jonville-Béra AP; Lorette G; Autret-Leca E;
    Ann Dermatol Venereol; 2003; 130(6-7):612-8. PubMed ID: 13679697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers.
    Cholez C; Trechot P; Schmutz JL; Faure G; Bene MC; Barbaud A
    Allergy; 2003 Nov; 58(11):1207-9. PubMed ID: 14616146
    [No Abstract]   [Full Text] [Related]  

  • 6. Diltiazem-induced acute generalised exanthematous pustulosis.
    Wakelin SH; James MP
    Clin Exp Dermatol; 1995 Jul; 20(4):341-4. PubMed ID: 8548996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous adverse reactions to calcium channel blockers.
    Tuchinda P; Kulthanan K; Khankham S; Jongjarearnprasert K; Dhana N
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):246-50. PubMed ID: 25268343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis induced by diltiazem: value of patch testing.
    Jan V; Machet L; Gironet N; Martin L; Machet MC; Lorette G; Vaillant L
    Dermatology; 1998; 197(3):274-5. PubMed ID: 9867362
    [No Abstract]   [Full Text] [Related]  

  • 9. Exfoliative dermatitis associated with diltiazem.
    Odeh M
    J Toxicol Clin Toxicol; 1997; 35(1):101-4. PubMed ID: 9022661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute generalized exanthematous pustulosis due to diltiazem: Investigation of cross-reactivity with other calcium channel blockers.
    Sáenz de Santa María García M; Noguerado-Mellado B; Rojas Pérez-Ezquerra P; Hernandez-Aragües I; De Barrio Fernández M
    J Allergy Clin Immunol Pract; 2016; 4(4):765-6. PubMed ID: 27025295
    [No Abstract]   [Full Text] [Related]  

  • 11. Diltiazem and subacute cutaneous lupus erythematosus-like lesions.
    Crowson AN; Magro CM
    N Engl J Med; 1995 Nov; 333(21):1429. PubMed ID: 7477141
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiform eruptions.
    Kitamura K; Kanasashi M; Suga C; Saito S; Yoshida S; Ikezawa Z
    J Dermatol; 1993 May; 20(5):279-86. PubMed ID: 8340532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute generalised exanthematosus pustulosis (AGEP) due to diltiazem--a case report].
    Barcik K; Protas-Drozd F; Weiss-Rostkowska W; Flis E; Placek W
    Kardiol Pol; 2009 Aug; 67(8):887-91. PubMed ID: 19784887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Photodistributed reticulated hyperpigmentation related to diltiazem.
    Jaka A; López-Pestaña A; Tuneu A; Lobo C; López-Núñez M; Ormaechea N
    Dermatol Online J; 2011 Jul; 17(7):14. PubMed ID: 21810399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).
    Sidoroff A; Dunant A; Viboud C; Halevy S; Bavinck JN; Naldi L; Mockenhaupt M; Fagot JP; Roujeau JC
    Br J Dermatol; 2007 Nov; 157(5):989-96. PubMed ID: 17854366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem-induced drug eruption sparing seborrheic keratoses.
    Heymann WR
    Cutis; 2000 Aug; 66(2):129-30. PubMed ID: 10955194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic allergic dermatitis caused by diltiazem.
    Opstrup MS; Guldager S; Zachariae C; Thyssen JP
    Contact Dermatitis; 2017 Jun; 76(6):364-365. PubMed ID: 28497625
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis.
    Girardi M; Duncan KO; Tigelaar RE; Imaeda S; Watsky KL; McNiff JM
    Am J Dermatopathol; 2005 Aug; 27(4):343-6. PubMed ID: 16121058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial hyperpigmentation caused by diltiazem hydrochloride.
    Desai N; Alexis AF; DeLeo VA
    Cutis; 2010 Aug; 86(2):82-4. PubMed ID: 20919601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact allergy to diltiazem cream.
    Leinonen PT; Riekki R; Oikarinen A
    Contact Dermatitis; 2010 Oct; 63(4):228-30. PubMed ID: 20831689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.